Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.


Journal

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
ISSN: 1122-0643
Titre abrégé: Monaldi Arch Chest Dis
Pays: Italy
ID NLM: 9307314

Informations de publication

Date de publication:
09 Nov 2020
Historique:
received: 14 07 2020
accepted: 10 09 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 20 11 2020
Statut: epublish

Résumé

COVID-19 is a pandemic with over 5 million cases worldwide. The disease has imposed a huge burden on health resources. Evaluation of clinical and epidemiological profiles of such patients can help in understanding and managing the outbreak more efficiently. This study was a prospective observational analysis of 200 diagnosed COVID-19 patients admitted to a tertiary care center from 20th march to 8th May 2020. All these patients were positive for COVID-19 by an oro-nasopharyngeal swab-rtPCR based testing. Analyses of demographic factors, clinical characteristics, comorbidities, laboratory parameters, and the outcomes were performed. The mean age of the population was 40 years with a slight male predominance (116 patients out of 200, 58%). A majority of the patients (147, 73.5 %) were symptomatic, with fever being the most common symptom (109, 54.5%), followed by cough (91, 45.5%). An older age, presence of symptoms and their duration, leukocytosis, a high quick SOFA score, a high modified SOFA score, need for ventilator support, an AST level more than 3 times the upper limit of normal (ULN), and a serum creatinine level of 2 mg/dl or greater were at a significantly higher risk of ICU admission and mortality. Presence of diabetes mellitus, AST > three times ULN, serum creatinine 2 mg/dl or higher, and a qSOFA score of 1 or higher were all associated with significantly greater odds of critical care requirement. Triage and severity assessment helps in deciding the requirement for a hospital stay and ICU admission for COVID-19 which can easily be done using clinical and laboratory parameters. A mild, moderate and severe category approach with defined criteria and treatment guidelines will help in judicious utilization of health-care resources, especially for developing countries like India.   *Other members of the Safdarjung Hospital COVID-19 working group: Balvinder Singh (Microbiology), MK Sen (Pulmonary Medicine), Shibdas Chakrabarti (Pulmonary Medicine), NK Gupta (Pulmonary medicine), AJ Mahendran (Pulmonary Medicine), Ramesh Meena (Medicine), G Usha (Anaesthesiology), Santvana Kohli (Anaesthesiology), Sahil Diwan (Anaesthesiology), Rushika Saksena (Microbiology), Vikramjeet Dutta (Microbiology), Anupam Kr Anveshi (Microbiology).

Identifiants

pubmed: 33169598
doi: 10.4081/monaldi.2020.1507
doi:

Substances chimiques

Creatinine AYI8EX34EU
Aspartate Aminotransferases EC 2.6.1.1
Alanine Transaminase EC 2.6.1.2

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Nitesh Gupta (N)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. niteshgupta2107@gmail.com.

Pranav Ish (P)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. pranavish2512@gmail.com.

Rohit Kumar (R)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. dr.rohitkumar@mail.com.

Nishanth Dev (N)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. devnishant@gmail.com.

Siddharth Raj Yadav (SR)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. drsid28@gmail.com.

Nipun Malhotra (N)

Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi. mr.nipun.malhotra@gmail.com.

Sumita Agrawal (S)

Department of Pulmonary Medicine, Medipulse Hospital, Jodhpur. drsumi84@gmail.com.

Rajni Gaind (R)

Department of Microbiology, Safdarjung Hospital, New Delhi. rgaind5@hotmail.com.

Harish Sachdeva (H)

Department of Anaesthesiology, Safdarjung Hospital, New Delhi. Sachdeva_hc04@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH